دورية أكاديمية
Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy
العنوان: | Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy |
---|---|
المؤلفون: | Wang L, Bi XW, Xia ZJ, Huang HQ, Jiang WQ, Zhang YJ |
المصدر: | OncoTargets and Therapy, Vol Volume 9, Pp 5875-5881 (2016) |
بيانات النشر: | Dove Medical Press, 2016. |
سنة النشر: | 2016 |
المجموعة: | LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
مصطلحات موضوعية: | extranodal NK/T-cell lymphoma, radiotherapy, prognosis, asparaginase, radiation-related toxicity, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
الوصف: | Liang Wang,1,2,* Xi-wen Bi,1,3,* Zhong-jun Xia,1,2 Hui-qiang Huang,1,3 Wen-qi Jiang,1,3 Yu-jing Zhang1,4 1State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 2Department of Hematologic Oncology, 3Department of Medical Oncology, 4Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China *These authors contributed equally to this work Abstract: Previous studies have found that radiotherapy (RT) dose less than 50 Gy resulted in inferior outcomes for early stage extranodal NK/T-cell lymphoma (ENKTL). Nowadays, induction chemotherapy (CT) followed by RT consolidation is often used. For patients who get complete response (CR) after CT, whether RT dose can be safely reduced or not remains unknown. This retrospective study compared the survival outcomes between patients who received higher dose (>50 Gy) and lower dose (≤50 Gy) RT after CR was attained by CT. One hundred and forty four patients of early stage ENKTL got CR after induction CT and received RT consolidation. Thirty-one patients received lower dose RT (median 46 Gy, range, 36–50 Gy), and 113 patients received higher dose RT (median 56 Gy, range, 52–66 Gy). In univariate survival analysis, age >60, local tumor invasion, and non-asparaginase-based CT were associated with inferior progression-free survival (PFS) and overall survival (OS). However, there were no differences in PFS and OS between patients treated with higher and lower dose RT, which was confirmed in the multivariate survival analysis. Furthermore, reduced dose RT did not affect local control rate. Most common RT-related side effects were grade 1/2 mucositis and dermatitis, and the incidence rate of grade 3 mucositis or dermatitis was lower in patients treated with reduced dose RT (9.7% vs 15.0% for mucositis, and 6.5% vs 17.7% for dermatitis). In conclusion, this study found that RT dose could be safely reduced without compromising survival outcomes and further improved RT-related side effects. Prospective randomized controlled trials are warranted to validate our findings. Keywords: extranodal NK/T-cell lymphoma, radiotherapy, prognosis, asparaginase, radiation-related toxicity |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 1178-6930 24409944 |
العلاقة: | https://www.dovepress.com/radiation-dose-reduction-for-patients-with-extranodal-nkt-cell-lymphom-peer-reviewed-article-OTTTest; https://doaj.org/toc/1178-6930Test |
الوصول الحر: | https://doaj.org/article/6be6cf2440994411834b919b88636552Test |
رقم الانضمام: | edsdoj.6be6cf2440994411834b919b88636552 |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 11786930 24409944 |
---|